MedPath

Multiform-based Baduanjin Exercise Prescription for Idiopathic Pulmonary Fibrosis disease (IPF) : study protocol for a randomized controlled trial

Phase 1
Not yet recruiting
Conditions
Idiopathic Pulmonary Fibrosis disease
Registration Number
ITMCTR2200005533
Lead Sponsor
Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) age between 35 and 80;
(2) The clinical symptoms were stable in the last two months;
(3) Patients diagnosed with IPF who satisfied the diagnostic criteria of ATS/ERS/JRS/ALAT 2018 [According to past medical history, laboratory tests and HRCT (typical UIP and Probable UIP)];
(4) Have not participated in other sports training systematically or intermittently in the last six months (no more than twice a week);
(5) No other disabling diseases (e.g. stroke, Parkinson's disease, etc.);
(6) Patients who agree to sign written informed consent.

Exclusion Criteria

(1) other chronic respiratory diseases;
(2) serious complications, including cardiovascular, liver or kidney disease;
(3) Inpatients whose condition is rapidly aggravating or in urgent need of other medication management;
(4) Skeletal muscle diseases or other diseases that may affect muscle strength assessment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.